Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Sorrento Therapeutics (SRNE)
NASDAQ:SRNE
Sorrento Therapeutics (SRNE) Stock Price & Analysis
0 Followers
SRNE Stock Chart & Stats
Day’s Range$0.26 - $0.4735
52-Week Range― - ―
Previous Close$0.39
Volume176.99M
Average Volume (3M)N/A
Market Cap
183.37M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding547,880,267
10 Day Avg. Volume116,832,490
30 Day Avg. Volume46,956,518
Standard Deviation0.36
R-Squared0.08
Alpha0.00166
Financial Highlights & Ratios
Price to Book (P/B)-1.42
Price to Sales (P/S)3.60
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$13.00Price Target Upside4130.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Sorrento Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SRNE FAQ
What was Sorrento Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Sorrento Therapeutics’s market cap?
Currently, no data Available
When is Sorrento Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sorrento Therapeutics’s earnings last quarter?
Currently, no data Available
Is Sorrento Therapeutics overvalued?
According to Wall Street analysts Sorrento Therapeutics’s price is currently Undervalued.
Does Sorrento Therapeutics pay dividends?
Sorrento Therapeutics does not currently pay dividends.
What is Sorrento Therapeutics’s EPS estimate?
Sorrento Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sorrento Therapeutics have?
Currently, no data Available
What happened to Sorrento Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sorrento Therapeutics?
Among the largest hedge funds holding Sorrento Therapeutics’s share is Graham Capital Management, L.P.. It holds Sorrento Therapeutics’s shares valued at 12K.
---
Sorrento Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.00 (4130.39% Upside)
$13.00 (4130.39% Upside)
Blogger Sentiment
Neutral
SRNE Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 831.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $2.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.1%
Last 30 Days ▲ 7.5%
Last 30 Days ▲ 7.5%
Learn more about TipRanks Smart Score
Company Description
Sorrento Therapeutics
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---